PRESS RELEASE: PCF Pharma Congress Features Results of Compliance Survey Results on Medical Affairs/Marketing, Drug Safety/Pharmacovigilence, and Compliance Program Management
  • Sponsored by the Pharmaceutical Compliance Forum
  • November 8 - 10, 2006
  • JW Marriott Hotel, Washington, DC
  • www.PharmaCongress.com
PRESS RELEASE
Phone: 800-684-4549
Email: registration@hcconferences.com
Website: www.PharmaCongress.com

WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE(TM) -- SEPTEMBER 20, 2006: The Seventh Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (the Pharma Congress), www.PharmaCongress.com, November 8 - 10, 2006, at the JW Marriott Hotel in Washington, DC announced today that it will feature an announcement of the results of the PCF Compliance Survey on Medical Affairs and Marketing, Drug Safety and Pharmacovigilence, and Managing your Compliance Program The Compliance Survey was funded by a grant from PricewaterhouseCoopers.

PCF COMPLIANCE SURVEY RESULTS:

A series of expert panels will present and analyze the results of the PCF Compliance Survey:

PCF Panel on Compliance Survey Results: Medical Affairs and Marketing
  • Nancy Coddington, PhD, Senior Director, Compliance, Operations and External Scientific Affairs, AstraZeneca Pharmaceuticals, Wilmington, DE
  • Stuart Kurlander. Esq., Partner, Latham & Watkins, Washington, DC
  • Robert G. Sikora, MS, R.Ph., Retired Vice President of Clinical Education, Pfizer, Inc., New York, NY
  • Anthony Farino, Partner, Life Sciences Advisory Leader, PricewaterhouseCoopers LLP, Chicago, IL (Moderator)
PCF Panel on Compliance Survey Results: Drug Safety and Pharmacovigilence
  • Maria C. Koster, Ph.D., Chief Executive Officer, Vigilex B.V., Rotterdam, The Netherlands
  • Joanna Haas, MD, Vice President, Pharmacovigilance, Genzyme Corporation, Cambridge, MA
  • Dan Kracov, Esq., Partner and Co-Head, Pharmaceutical and Medical Device Practice, Arnold & Porter, Washington, DC
  • Dennis Mackey, Division of Prescription Drug Compliance and Surveillance, Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, Washington, DC
  • Peter Claude, Partner, Life Sciences Advisory Group, PricewaterhouseCoopers LLP, Florham Park, NJ (Moderator)
PCF Panel on Compliance Survey Results: Managing your Compliance Program
  • John P. Hansen, Director of Member Services & Government Affairs, Ethics & Compliance Officer Association, Waltham, MA
  • Robert A. Freeman, US Compliance Officer and Compliance Counsel, Serono, Inc., Boston, MA
  • Jonathan K. Sprole, Vice President and Deputy General Counsel and Chief Compliance Officer, Bristol Myers Squibb, New York, NY
  • Win Swenson, Esq., Partner, Compliance Systems Legal Group, Washington, DC
  • Brian Riewerts, Partner, Life Sciences Governance, Risk and Compliance Advisory Leader, PricewaterhouseCoopers LLP, Washington, DC (Moderator)
GOVERNMENT KEYNOTE SPEAKERS

Michael Loucks, Esq.
Chief of the Health Care Fraud Unit, Assistant U.S. Attorney, US Attorney's Office for the District of Massachusetts, Boston, MA
Lewis Morris, Esq.
Chief Counsel, Office of Inspector General, Department of Health and Human Services, Washington, DC
Jim Sheehan, Esq.
Assistant US Attorney, United States Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA

OTHER KEYNOTE SPEAKERS

Troyen A. Brennan, MD, MPH
Senior Vice President and Chief Medical Officer, Aetna Inc., Professor of Medicine, Harvard Medical School, Professor of Law and Public Health, Harvard School of Public Health, Former President and Chief Executive Officer, Brigham and Women's Physician's Organization, Hartford, CT
Randy Cohen
Author, "The Ethicist" column, The New York Times Magazine, New York, NY
Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University, Princeton, NJ
P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman, Merck & Co., Bedminster, NJ
Sherron S. Watkins
Former Vice President, Enron Corporation, Author, Power Failure, the Inside Story of the Collapse of Enron, TIME Magazine 2002 Person of the Year, Glamour Magazine, 2002 Women of the Year, Court TV Scales of Justice Award and Everyday Hero's Award, Houston, TX

CONGRESS CO CHAIRS
Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company
Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP, Stamford, CT

FEATURING THE FOLLOWING SPECIAL SESSIONS AND ACTIVITIES
  • Pharmaceutical Compliance Primer
  • Annual State of the Pharmaceutical Compliance Enterprise Address by Bert Weinstein, Esq., Vice President, Corporate Compliance, Purdue Pharma LP
  • Overview of OIG Pharma Compliance Initiatives and Regulators Roundtable
  • PCF Compliance Survey Results on Medical Affairs and Marketing, Drug Safety and Pharmacovigilence, and Managing your Compliance Program
  • Presentation of PCF First Annual Compliance Best Practice Awards
  • Pharma Congress Hypothetical Compliance Vignettes and Response by Panel of Compliance Experts
  • Pharmaceutical Compliance Family Feud - The Game with Real Life Implications for the Nation's Pharmaceutical Manufacturers
  • Monday Company Best Auditing, Monitoring and Investigations Policy and Procedure Poster Board and Exchange Networking Reception
  • Tuesday Meet the Regulator Networking Reception
  • Compliance in a Highly Litigious World: Creating Good Documents and Avoiding Bad Ones
  • Advanced Tactics for Negotiation with the Government and Preparing for a CIA
  • Self Assessments: Adding Value to Your Compliance Program
  • The Special Concerns of Small Cap Companies: Building a Compliance Program with Limited Resources
  • Death by a Thousand Paper Cuts: State Laws and Pharmaceutical Companies
  • Qui Tam Suits: The Barometer of Future Enforcement Actions
  • Best Practices in Compliance Program Auditing
  • Managing Compliance through Technology
  • Integrating Compliance with Business: Developing a Business-Facing Compliance Program
  • Compliance Branding
  • Off Label Controls and Monitoring
  • Fair Market Value: Where, When and How to Use It
  • Kickbacks: How to Develop Internal Monitoring Programs
  • Grants, CME and Compliance
  • FCPA and Other International Compliance Issues
  • Compliance vs. the Law Department: How to Work Together
SPONSORED BY THE PHARMACEUTICAL COMPLIANCE FORUM:

The Pharma Congress is sponsored by the Pharmaceutical Compliance Forum (PCF), www.PharmaComplianceForum.org, a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The organization is open to others in the industry and has more than doubled in membership since its founding. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a three-day compliance congress each Fall.

AN INVITATION TO JOIN US

Dear pharma compliance professional,

We hope that you will join us and help us to transform the Pharma Congress to reflect a new style of learning and knowledge exchange. You may register on the Pharma congress website at www.PharmaCongress.com.

Sincerely,

PCF Special Pharma Congress Planning Committee:

Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company (Co chair)

Arjun Rajaratnam
Vice President and Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline (Co chair)

Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation (Co chair)

Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP (Co chair)

John Alivernini, Esq.
Vice President and Chief, Compliance Officer, Wyeth Pharmaceuticals

John T. Bentivoglio, Esq.
Partner, King & Spalding LLP

David B. Chandler, Ph.D., DABT
Associate Director of Outcomes and Analysis Corporate Compliance, Amgen

Robert A. Freeman
US Compliance Officer and Compliance Counsel, Serono, Inc.

Wendy C. Goldstein, Esq.
Partner, Epstein Becker & Green
 Peter N. Grant, JD, Ph.D.
President, Health Care, Conference Administrators, LLC

Deb Ghosh
Ernst & Young LLP

Keith M. Korenchuk, JD, MPH
Partner, Covington & Burling LLP

Steve Mohr, Esq.
Deputy Compliance Officer, AstraZeneca

Jody Noon, RN, JD
National Leader for the Life Sciences & Health Care Regulatory Practice, Deloitte & Touche LLP

Brian Riewerts
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP

Catherine Sazdanoff
Divisional Vice President, Ethics and Compliance, Abbott Laboratories

Michael Shaw
Deputy Compliance Officer, Novartis Pharmaceuticals Corporation

Paul J. Silver
Managing Director, Huron Consulting Group

Jonathan K. Sprole
Chief Compliance Officer, Bristol-Myers Squibb Company

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information go to www.pharmacongress.com/promotional/index.html or contact Joni Lipson, Exhibit Manager, 215-599-6626 phone, 215-545-8107 fax, joni.lipson@rmpinc.com.

CONGRESS REGISTRATION INFORMATION

Register online at www.pharmacongress.com/registration.html, call 800-684-4549, email registration@hcconferences.com or write:

    Pharma Congress Office
    7790 Barberry Ave.
    Yucca Valley CA USA 92284
SPONSORED BY:


GRANTORS:
DIAMOND

PLATINUM

GOLD

SILVER

BRONZE









COSPONSORED BY:
ASSOCIATIONS
















PUBLICATIONS